Progress in the endovascular treatment of intermittent claudication: rationale for changes in the TASC classification.
Progress in the endovascular treatment of intermittent claudication: rationale for changes in the TASC classification.
复制标题
间歇性跛行的血管内治疗进展：TASC 分类变化的理由。
DOI：
10.1053/j.semvascsurg.2007.02.010
复制
发表时间：
2007
影响因子：
2.5
通讯作者：
C. Ryjewski
中科院分区：
文献类型：
--
作者：
John V. White;C. Ryjewski
2000年出版的《跨大西洋社会共识指南》(TASC)包含了一个新的外周动脉疾病治疗分类系统。这种分类是基于对干预的反应，与技术和技术无关。该系统的目标是根据已发表的最高水平的证据，为下肢动脉闭塞症患者指明最佳的治疗形式，血管内(TASC A)或外科(TASC D)。这些病变没有强有力的证据支持，但血管内(TASC B)或手术(TASC C)反应良好的可能性更大，被认为是需要进一步评估的关键问题。TASC工作组的意图是定期更新这一分类。病变的位置、长度、钙化和闭塞都对外周动脉疾病的成功和持久的血管内治疗构成了巨大的挑战。自2000年以来，血管专家利用新技术和新技术系统地解决了这些变量，以改善结果。这些改进已经反映在TASC II中列出的初始TASC分类系统的每一类病变的变化中。这篇综述为这些变化提供了一个循证的理由。
Published in 2000, the TransAtlantic Inter-Societal Consensus (TASC) guidelines contained a new classification system for treatment of peripheral arterial disease. The classification was based upon response to intervention and was independent of technology and techniques. The goal of this system was to indicate the best form of treatment, endovascular (TASC A) or surgical (TASC D), for patients with lower-extremity arterial occlusive disease based upon highest levels of evidence in published reports. Those lesions without strongly supportive evidence, but with a greater likelihood of good response to endovascular (TASC B) or surgery (TASC C), were noted as critical issues requiring additional assessment. It was the intent of the TASC Working Group that this classification be periodically updated. Lesion location, length, calcification, and occlusion have each posed significant challenges to the successful and enduring endovascular treatment of peripheral arterial disease. Since 2000, vascular specialists have systematically addressed these variables with new technology and techniques to improve results. These improvements have been reflected in changes to lesions included in each category of the initial TASC classification system as listed in TASC II. This review provides an evidence-based rationale for these changes.